FREE Account Opening + No Clearing Fees
Loading...
December 16, 2021 - December 20, 2021

Supriya Lifescience IPO Latest News Today

Track all the latest updates and news of Supriya Lifescience IPO.

  1. Emcure Pharmaceuticals Set to Debut on Dalal Street with IPO on July 3

    June 28, 2024 6:51:00 PM

    Emcure Pharmaceuticals is launching its IPO on Dalal Street on July 3, 2024. Market insights about this highly anticipated public offering.

    Published by : tech
  2. Supriya Lifescience (SUPRIYA LIFESCI.) Share Price

    June 10, 2024 3:31:00 AM

    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.

    Published by : India Infoline
  3. Emcure planning acquisition, in-licensing deals

    June 29, 2024 2:20:00 AM

    Emcure Pharmaceuticals upcoming initial public offering (IPO) wil give the company access to new growth capital which it will use to fund inorganic growth and explore acquisitions, said managing ...

    Published by : The Financial Express on MSN
  4. Fierce Biotechs Quarterly IPO and M&A Roundup: Q224

    July 1, 2024 2:30:00 PM

    Biopharma deal activity plummeted down to Earth in the second quarter, with just a handful of M&A transactions and IPOs studding the mostly dark skies. | The slow quarter follows an exciting first one ...

    Published by : FierceBiotech
  5. Third Rocks Rapport reveals upsized $154M IPO

    June 7, 2024 2:30:00 PM

    Just a few days after Rapport Therapeutics revealed plans for a $122 million IPO, the epilepsy biotech has unveiled an upsized $154 million offering. The Third Rock company�s IPO consists of 8 ...

    Published by : FierceBiotech
  6. CrowdStrike: Five Years Since IPO And Just Getting Started

    June 12, 2024 7:17:00 PM

    CrowdStrike marks the 5-year anniversay of its IPO with significant milestones and momentum and ... [+] being added to the S&P 500. As CrowdStrike marks the fifth anniversary of its IPO ...

    Published by : Forbes
  7. Newsmax Considers IPO With Private Placement of Up to $225 Million

    June 10, 2024 10:20:00 PM

    Media network Newsmax plans to publicly list its shares later this year and is looking to raise capital beforehand via a private placement. Boca Raton, Fla.-based Newsmax said Monday in an ...

    Published by : Wall Street Journal
  8. Conservative Cable News Channel Newsmax Wants to IPO. Here�s Why

    June 13, 2024 6:11:00 AM

    And much like Trump�s company (or for that matter stocks like GameStop and AMC Entertainment), Ruddy is hoping that an IPO would engage retail investors, many of whom would express their ...

    Published by : The Hollywood Reporter
  9. Newsmax eyes IPO and launches $225M placement

    June 11, 2024 5:21:00 PM

    Shares in Rumble, a conservative alternative to YouTube that went public in 2022, are up more than 33% year-to-date, but are down 40% overall since its IPO. Shares in Public Sq., a sales ...

    Published by : MSN
  10. Shein IPO Should Be A No Brainer Investment, Yet Caution Reigns

    June 12, 2024 5:15:00 PM

    The founder of Gen Z super brand Shein must be wondering whether the company will ever catch a break over the long-running soap opera that is the fashion retailer�s much vaunted IPO. On the face ...

    Published by : Forbes

Supriya Lifescience IPO Alerts

1. Supriya Lifescience IPO Listing Date & Info  Monday, December 27, 2021 4:41:34 AM

The IPO Shares of Supriya Lifescience Limited IPO are proposed to list on Tuesday, December 28, 2021 at BSE, NSE. The public issue of Supriya Lifescience IPO was opened on Dec 16, 2021 and closed for subscription on Dec 20, 2021. Supriya Lifescience IPO Listing Date and Information:

Supriya Lifescience Limited Listing Date

Listing DateTuesday, December 28, 2021
BSE Script Code543434
NSE SymbolSUPRIYA
Listing InB Group of Securities
ISININE07RO01027
Issue Price₹274 Per Equity Share
Face Value₹2 Per Equity Share

2. Supriya Lifescience IPO Allotment Status  Thursday, December 23, 2021 11:51:55 PM

The allotment status of Supriya Lifescience Limited IPO is now available online. The public issue of Supriya Lifescience IPO was open on Dec 16, 2021 and closed for subscription on Dec 20, 2021. The equity shares of the company to be list at BSE, NSE.

3. Supriya Lifescience IPO Opens  Saturday, December 11, 2021 3:04:05 AM

Supriya Lifescience Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 2 aggregating up to Rs 700.00 Crore. The price for the issue has been set at Rs - Rs Per Equity Share.

Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. The company has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between Fiscal 2017 and 2021. The company is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021 in terms of volume.

The issue opens on Dec 16, 2021 and closes for subscription on Dec 20, 2021. The equity shares of the company to be list at BSE, NSE.

4. Supriya Lifescience IPO Closes  Saturday, December 11, 2021 3:04:05 AM

The issue of Supriya Lifescience Limited opens on Dec 16, 2021 and closes for subscription on Dec 20, 2021. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs - Rs Per Equity Share.

Supriya Lifescience IPO News & Events FAQs

The Supriya Lifescience IPO is proposed to open on December 16, 2021. The IPO application ends on December 20, 2021.

Retail investors can apply in the retail or non-institutional investor category from December 16, 2021 to December 20, 2021. The Supriya Lifescience IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Supriya Lifescience IPO will open for subscription on December 16, 2021. The public issue will close on December 20, 2021.